Selectivity of von Willebrand factor triplet bands towards heparin binding supports structural model

European Journal of Haematology

Volumn 62, Issue 3, 1999, Pages 169-173

  Fischer, Bernhard E ^a,b   Thomas, Kathy B ^a   Schlokat, U ^a   Dorner, F ^a  

^a BAXTER HEALTHCARE CORPORATION   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Heparin affinity; Multimer structure; Proteolysis; Von Willebrand factor

Indexed keywords

VON WILLEBRAND FACTOR;

AFFINITY CHROMATOGRAPHY; AGAR GEL ELECTROPHORESIS; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; DISULFIDE BOND; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MEGAKARYOCYTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS REGULATION; RECEPTOR AFFINITY; STRUCTURE ANALYSIS; VASCULAR ENDOTHELIUM;

EID: 0032987572     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1999.tb01740.x     Document Type: Article

References (20)

1. RUGGERI ZM, WARE J. The structure and function of von Willebrand factor. Thromb Haemost 1992;67:594-599.
2. RUGGERI ZM, ZIMMERMAN TS. The structure and function of von Willebrand factor. Blood 1991;57:1140-1143.
3. RUGGERI ZM, WARE J. Von Willebrand factor. FASEB J 1993;7:308-316.
4. MANNUCCI PM, ABILDGAARD CF, GRALNICK HR, et al. Multicenter comparison of von Willebrand factor multimer sizing techniques. Thromb Haemost 1985;54:873-877.
5. MANNUCCI PM, LATTUADA A, RUGGERI ZM. Proteolysis of von Willebrand factor in therapeutic plasma concentrates. Blood 1994;83:3018-3027.
6. FURLAN M, ROBLES R, AFFOLTER D, MEYER D, BAILLOD P, LäMMLE B. Triplet structure of von Willebrand factor reflects proteolytic degradation of high molecular weight multimers. Proc Natl Acad Sci USA 1993;90:7503-7507.
7. FURLAN M, ROBLES R, LÄMMLE B. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood 1996;87:4223-4234.
8. DENT JA, BERKOWITZ SD, WARE J, KASPER CK, RUGGERI ZM. Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor. Proc Natl Acad Sci USA 1990;87:6306-6310.
9. FISCHER BE, THOMAS KB, SCHLOKAT U, DORNER F. Triplet structure of human von Willebrand factor. Biochem J 1998;331:483-488.
10. FISCHER BE, MITTERER A, SCHLOKAT U, DENBOUWMEESTER R, DORNER F. Structural analysis of recombinant von Willebrand factor: identification of hetero- and homodimers. FEBS Lett 1994;351:345-348.
11. FISCHER BE, SCHLOKAT U, MITTERER M, et al. Structural analysis of recombinant von Willebrand factor produced at industrial scale fermentation of transformed CHO cells coexpressing recombinant furin. FEBS Lett 1995;375:259-262.
12. FISCHER BE, SCHLOKAT U, REITER M, MUNDT W, DORNER F. Biochemical and functional characterization of recombinant von Willebrand factor produced on a large scale. Cell Mol Life Sci 1997;53:943-950.
13. FISCHER B, KRAMER G, MITTERER A, et al. Effect of multimerization of human and recombinant von Willebrand factor on platelet aggregation, binding to collagen and binding of coagulation factor VIII. Thromb Res 1996;84:55-66.
14. RAINES G, AUMANN H, SYKES S, STREET A. Multimeric analysis of von Willebrand factor by molecular sieving electrophoresis in sodium dodecyl sulfate gel. Thromb Res 1990;60:201-212.
15. AIHARA M, SAWADA Y, UENO K, et al. Visualization of von Willebrand factor multimers by immunoenzymatic stain using avidin-biotin peroxidase complex. Thromb Haemost 1986;55:263-267.
16. SOBEL M, SOLER DF, KERMODE JC, HARRIS RB. Localization and characterization of a heparin binding domain peptide of human von Willebrand factor. J Biol Chem 1992;267:8857-8862.
17. MOHRI H, YOSHIOKA A, ZIMMERMAN TS, RUGGERI Z. Isolation of the von Willebrand factor domain interacting with platelet glycoprotein Ib, Heparin, and collagen and characterization of its three distinct functional sites. J Biol Chem 1989;264:17 361-17 367.
18. SIXMA JJ, SCHIPHORST ME, VERWIJ CL, PANNEKOEK H. Effects of deletion of the A1 domain of von Willebrand factor on its binding to heparin, collagen and platelets in the presence of ristocetin. Eur J Biochem 1991;196:369-375.
19. PIETU G, MEULIEN P, CHEREL G, et al. Production in Escherichia coli of a biologically active subfragment of von Willebrand factor corresponding to the platelet glycoprotein Ib, collagen and heparin binding domains. Biochem Biophys Res Commun 1989;164:1339-1347.
20. CRUZ MA, HANDIN RI, WISE RJ. The interaction of the von Willebrand factor A1 domain with platelet glycoprotein Ib/IX. J Biol Chem 1993;268:21 238-21 245.